Hims agrees to limit compounding, ending feud with Novo Nordisknews2026-03-09T14:44:20+00:00March 9th, 2026|Endpoints News|
Eli Lilly’s new program aims to boost employer coverage of GLP-1snews2026-03-05T17:02:54+00:00March 5th, 2026|Endpoints News|
How hospitals have shifted from experimenting with AI to justifying its costnews2026-03-05T14:00:48+00:00March 5th, 2026|Endpoints News|
Old school healthcare is warming up to technews2026-03-03T21:46:08+00:00March 3rd, 2026|Endpoints News|
Corrected: Hims’ pharmacy partner won’t reintroduce GLP-1 pill pulled from marketnews2026-03-03T14:24:24+00:00March 3rd, 2026|Endpoints News|
CMS’ Chris Klomp on what it will take for AI to succeed in healthcarenews2026-03-03T14:00:45+00:00March 3rd, 2026|Endpoints News|
Investors are pumping money into AI tools for health insurersnews2026-02-27T14:00:27+00:00February 27th, 2026|Endpoints News|
Why did my doctor push Grail’s dubious cancer test?news2026-02-26T17:09:28+00:00February 26th, 2026|Endpoints News|
Salma Health raises $80M for its clinics to treat brain healthnews2026-02-26T14:00:16+00:00February 26th, 2026|Endpoints News|
